Alba Diaz-Maiques
Manchester, ENG M204BX, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies.
Journal: Cancer cell
Published: July 08, 2022
HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block.
Journal: Oncogene
Published: January 04, 2022
LSD1 inhibitors disrupt the GFI1 transcription repressor complex.
Journal: Molecular & cellular oncology
Published: May 14, 2018
Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1.
Journal: Journal of medicinal chemistry
Published: September 12, 2017
The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia.
Journal: Leukemia
Published: June 21, 2017
Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1.
Journal: Bioorganic & medicinal chemistry letters
Published: March 30, 2017
MAPK8-mediated stabilization of SP1 is essential for RUNX1-RUNX1T1 - driven leukaemia.
Journal: British journal of haematology
Published: June 11, 2015
Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs.
Journal: Leukemia
Published: February 01, 2012
Abrogation of RUNX1 gene expression in de novo myelodysplastic syndrome with t(4;21)(q21;q22).
Journal: Haematologica
Published: November 22, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026